| human | Q5 |
| P6178 | Dimensions author ID | 01263642461.28 |
| P10949 | IRIS UNICAMPANIA author ID | 04014 |
| P9843 | IRIS UNINA author ID | 26159 |
| P496 | ORCID iD | 0000-0002-4084-8044 |
| P1153 | Scopus author ID | 7007165229 |
| P10861 | Springer Nature person ID | 01263642461.28 |
| P734 | family name | Marinelli | Q21491936 |
| Marinelli | Q21491936 | ||
| Marinelli | Q21491936 | ||
| P735 | given name | Luciana | Q11247717 |
| Luciana | Q11247717 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q51761799 | 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists. |
| Q44612728 | A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity |
| Q58043793 | A more detailed picture of the interactions between virtual screening-derived hits and the DNA G-quadruplex: NMR, molecular modelling and ITC studies |
| Q38904705 | A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach. |
| Q54699195 | A stereoselective approach to peptidomimetic BACE1 inhibitors. |
| Q46615145 | Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model. |
| Q37718142 | Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma. |
| Q45788712 | Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation |
| Q34372481 | Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase |
| Q58855699 | Benzofuroxane Derivatives as Multi-Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies |
| Q39033002 | Beyond radio-displacement techniques for identification of CB1 ligands: the first application of a fluorescence-quenching assay |
| Q34567390 | Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids |
| Q92285309 | Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication |
| Q46062883 | Breaking the dogma of the metal-coordinating carboxylate group in integrin ligands: introducing hydroxamic acids to the MIDAS to tune potency and selectivity |
| Q36209502 | Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity |
| Q40237573 | Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations |
| Q35505109 | Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells |
| Q47785783 | Computer-Aided Identification and Lead Optimization of Dual Murine Double Minute 2 and 4 Binders: Structure-Activity Relationship Studies and Pharmacological Activity |
| Q58855726 | Conformational Control of Integrin-Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch |
| Q44571443 | Conformational analysis of furanoid epsilon-sugar amino acid containing cyclic peptides by NMR spectroscopy, molecular dynamics simulation, and X-ray crystallography: evidence for a novel turn structure |
| Q58855652 | Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides |
| Q35057450 | Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3β inhibitors |
| Q39927300 | Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism. |
| Q42726938 | Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4. |
| Q58856006 | Designed Beta-Turn Mimic Based on the Allylic-Strain Concept: Evaluation of Structural and Biological Features by Incorporation into a Cyclic RGD Peptide (Cyclo(-L-arginylglycyl-L--aspartyl-)) |
| Q35228036 | Discovery of covalent inhibitors of glyceraldehyde-3-phosphate dehydrogenase, a target for the treatment of malaria |
| Q44604117 | Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design |
| Q48449904 | Dual Inhibition of PDK1 and Aurora Kinase A: An Effective Strategy to Induce Differentiation and Apoptosis of Human Glioblastoma Multiforme Stem Cells. |
| Q47978998 | Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer |
| Q27308091 | Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments |
| Q58855764 | Ensemble-Docking Approach on BACE-1: Pharmacophore Perception and Guidelines for Drug Design |
| Q48218323 | Ensemble-docking approach on BACE-1: pharmacophore perception and guidelines for drug design |
| Q46475804 | Ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as novel, highly potent, and safe antianxiety agent |
| Q27727757 | Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists |
| Q39060815 | Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence |
| Q52585344 | From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands. |
| Q37971989 | From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair |
| Q90920995 | Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides |
| Q47925753 | Highly selective cyclic hexapeptides antagonist of GPIIb-IIIa by multiple N-methylation |
| Q42631272 | Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding |
| Q45007063 | Human integrin alphavbeta5: homology modeling and ligand binding |
| Q34232241 | Human recombinant beta-secretase immobilized enzyme reactor for fast hits' selection and characterization from a virtual screening library |
| Q58855714 | Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications |
| Q45996569 | Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor. |
| Q39358775 | Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α. |
| Q58308143 | Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: A first round of lead optimization |
| Q33321389 | Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity |
| Q34030885 | Increasing αvβ3 selectivity of the anti-angiogenic drug cilengitide by N-methylation. |
| Q47192221 | Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR Inhibitors |
| Q53790957 | Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas. |
| Q51068245 | Ligand based approach to L-type calcium channel by imidazo[2,1-b]thiazole-1,4-dihydropyridines: from heart activity to brain affinity. |
| Q46563136 | Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonists |
| Q52664347 | Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells. |
| Q38774807 | Locking PDK1 in DFG-out conformation through 2-oxo-indole containing molecules: Another tools to fight glioblastoma |
| Q36946655 | Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells |
| Q91291432 | Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts |
| Q33777769 | Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition |
| Q46921733 | Multiple N-methylation by a designed approach enhances receptor selectivity |
| Q87907457 | N-Methylation of isoDGR Peptides: Discovery of a Selective α5β1-Integrin Ligand as a Potent Tumor Imaging Agent |
| Q58308205 | N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis |
| Q58308148 | N-O-Isopropyl sulfonamido-based hydroxamates: Kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors |
| Q41242092 | N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse Transcriptase |
| Q42732271 | New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists |
| Q36004162 | New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer |
| Q49054463 | New insight into the central benzodiazepine receptor-ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds. |
| Q39592595 | Non-nucleoside inhibitors of human adenosine kinase: synthesis, molecular modeling, and biological studies. |
| Q39712416 | Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation. |
| Q120364216 | Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors |
| Q37014638 | Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action |
| Q58855692 | Novel peptidomimetics as BACE-1 inhibitors: Synthesis, molecular modeling, and biological studies |
| Q37107512 | Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities |
| Q47600958 | Overcoming the Lack of Oral Availability of Cyclic Hexapeptides: Design of a Selective and Orally Available Ligand for the Integrin αvβ3. |
| Q38902274 | Pharmacological folding chaperones act as allosteric ligands of Frizzled4. |
| Q35127140 | Pharmacophoric modifications lead to superpotent αvβ3 integrin ligands with suppressed α5β1 activity |
| Q37695391 | Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors |
| Q39735845 | Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models |
| Q58856002 | Probing Integrin Selectivity: Rational Design of Highly Active and Selective Ligands for the α5β1 and αvβ3 Integrin Receptor |
| Q57692568 | Progresses in the pursuit of aldose reductase inhibitors: The structure-based lead optimization step |
| Q36470957 | Protein flexibility in virtual screening: the BACE-1 case study |
| Q58855743 | Pursuing Aldose Reductase Inhibitors through in Situ Cross-Docking and Similarity-Based Virtual Screening |
| Q27690775 | Rational improvement of the affinity and selectivity of integrin binding of grafted lasso peptides |
| Q58855681 | Receptor-Bound Conformation of Cilengitide Better Represented by Its Solution-State Structure than the Solid-State Structure |
| Q35749668 | Sampling protein motion and solvent effect during ligand binding |
| Q91110442 | Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide |
| Q39094755 | Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models |
| Q57976340 | Shading the TRF2 Recruiting Function: A New Horizon in Drug Development |
| Q57976362 | Shooting for Selective Druglike G-Quadruplex Binders: Evidence for Telomeric DNA Damage and Tumor Cell Death |
| Q55457041 | Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme. |
| Q46146590 | Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutations |
| Q38811936 | Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands |
| Q37989213 | State-of-the-art methodologies for the discovery and characterization of DNA G-quadruplex binders. |
| Q27660548 | Structural and conformational requisites in DNA quadruplex groove binding: another piece to the puzzle |
| Q47417227 | Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist |
| Q39020023 | Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors |
| Q40435723 | Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid |
| Q39041318 | Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents. |
| Q39032395 | Structure-based optimization of tyrosine kinase inhibitor CLM3. Design, synthesis, functional evaluation, and molecular modeling studies |
| Q44351086 | Syntheses, biological evaluation, and molecular modeling of 18F-labeled 4-anilidopiperidines as mu-opioid receptor imaging agents |
| Q58856010 | Synthesis and NMR Structure of Peptidomimetic α4β7-Integrin Antagonists |
| Q35871254 | Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors |
| Q42556925 | Synthesis and biological evaluation of CTP synthetase inhibitors as potential agents for the treatment of African trypanosomiasis |
| Q58855665 | Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands |
| Q58855708 | Tailoring of Integrin Ligands: Probing the Charge Capability of the Metal Ion-Dependent Adhesion Site |
| Q58043828 | Tandem Application of Virtual Screening and NMR Experiments in the Discovery of Brand New DNA Quadruplex Groove Binders |
| Q57976357 | The G-Triplex DNA |
| Q27703999 | The ring residue proline 8 is crucial for the thermal stability of the lasso peptide caulosegnin II |
| Q46798118 | Urotensin-II receptor ligands. From agonist to antagonist activity |
| Q51759244 | Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A₃ adenosine receptor antagonists. |
| Q39013934 | p53 functional inhibitors behaving like pifithrin-β counteract the Alzheimer peptide non-β-amyloid component effects in human SH-SY5Y cells |
Search more.